Igs2em23(CAG-EGFR*T790M*L858R)Gpt
Endonuclease-mediated Allele Detail
|
Symbol: |
Igs2em23(CAG-EGFR*T790M*L858R)Gpt |
Name: |
intergenic site 2; endonuclease-mediated mutation 23, GemPharmatech Co., Ltd |
MGI ID: |
MGI:7300636 |
Synonyms: |
Igs2em1Cin(CAG-LSL-EGFR(T790M L858R)) |
Gene: |
Igs2 Location: unknown Genetic Position: Chr11, Syntenic
|
Alliance: |
Igs2em23(CAG-EGFR*T790M*L858R)Gpt page
|
|
|
Allele Type: |
|
Endonuclease-mediated (Conditional ready, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Igs2em23(CAG-EGFR*T790M*L858R)Gpt expresses
1 gene
Knock-in expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
EGFR (1956) |
|
|
|
|
|
Mutation details: CRISPR-targeting inserted a CAG promoter, floxed STOP cassette, and human gene coding sequence with mutation that results in the amio acid substitution of threonine with methionine at position 790 (T790M) and leucine with arginine at position 858 (L858R).
(J:293217)
|
Inheritance: |
|
Not Specified |
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Igs2 Mutation: |
71 strains or lines available
|
|
|